KR100427960B1 - 상승 작용성 제초제 혼합물 - Google Patents
상승 작용성 제초제 혼합물 Download PDFInfo
- Publication number
- KR100427960B1 KR100427960B1 KR10-1998-0703305A KR19980703305A KR100427960B1 KR 100427960 B1 KR100427960 B1 KR 100427960B1 KR 19980703305 A KR19980703305 A KR 19980703305A KR 100427960 B1 KR100427960 B1 KR 100427960B1
- Authority
- KR
- South Korea
- Prior art keywords
- per
- amount
- mixture
- observed
- experiment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 230000002195 synergetic effect Effects 0.000 title claims abstract description 48
- 230000002363 herbicidal effect Effects 0.000 title claims abstract description 12
- -1 pyrazosupuron-ethyl Chemical compound 0.000 claims abstract description 23
- LLQPHQFNMLZJMP-UHFFFAOYSA-N Fentrazamide Chemical compound N1=NN(C=2C(=CC=CC=2)Cl)C(=O)N1C(=O)N(CC)C1CCCCC1 LLQPHQFNMLZJMP-UHFFFAOYSA-N 0.000 claims abstract description 8
- WZDDLAZXUYIVMU-UHFFFAOYSA-N bromobutide Chemical compound CC(C)(C)C(Br)C(=O)NC(C)(C)C1=CC=CC=C1 WZDDLAZXUYIVMU-UHFFFAOYSA-N 0.000 claims abstract description 6
- BWUPSGJXXPATLU-UHFFFAOYSA-N dimepiperate Chemical compound C=1C=CC=CC=1C(C)(C)SC(=O)N1CCCCC1 BWUPSGJXXPATLU-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004009 herbicide Substances 0.000 claims abstract description 6
- XIGAUIHYSDTJHW-UHFFFAOYSA-N mefenacet Chemical compound N=1C2=CC=CC=C2SC=1OCC(=O)N(C)C1=CC=CC=C1 XIGAUIHYSDTJHW-UHFFFAOYSA-N 0.000 claims abstract description 6
- DEDOPGXGGQYYMW-UHFFFAOYSA-N molinate Chemical compound CCSC(=O)N1CCCCCC1 DEDOPGXGGQYYMW-UHFFFAOYSA-N 0.000 claims abstract description 6
- FFSSWMQPCJRCRV-UHFFFAOYSA-N quinclorac Chemical compound ClC1=CN=C2C(C(=O)O)=C(Cl)C=CC2=C1 FFSSWMQPCJRCRV-UHFFFAOYSA-N 0.000 claims abstract description 6
- VYNOULHXXDFBLU-UHFFFAOYSA-N Cumyluron Chemical compound C=1C=CC=CC=1C(C)(C)NC(=O)NCC1=CC=CC=C1Cl VYNOULHXXDFBLU-UHFFFAOYSA-N 0.000 claims abstract description 5
- BXEHUCNTIZGSOJ-UHFFFAOYSA-N Esprocarb Chemical compound CC(C)C(C)N(CC)C(=O)SCC1=CC=CC=C1 BXEHUCNTIZGSOJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000005502 Cyhalofop-butyl Substances 0.000 claims abstract description 4
- TYIYMOAHACZAMQ-CQSZACIVSA-N Cyhalofop-butyl Chemical group C1=CC(O[C@H](C)C(=O)OCCCC)=CC=C1OC1=CC=C(C#N)C=C1F TYIYMOAHACZAMQ-CQSZACIVSA-N 0.000 claims abstract description 4
- LVKTWOXHRYGDMM-UHFFFAOYSA-N Naproanilide Chemical compound C=1C=C2C=CC=CC2=CC=1OC(C)C(=O)NC1=CC=CC=C1 LVKTWOXHRYGDMM-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000005567 Imazosulfuron Substances 0.000 claims abstract description 3
- NAGRVUXEKKZNHT-UHFFFAOYSA-N Imazosulfuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)C=2N3C=CC=CC3=NC=2Cl)=N1 NAGRVUXEKKZNHT-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- LFULEKSKNZEWOE-UHFFFAOYSA-N propanil Chemical compound CCC(=O)NC1=CC=C(Cl)C(Cl)=C1 LFULEKSKNZEWOE-UHFFFAOYSA-N 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- YLPGTOIOYRQOHV-UHFFFAOYSA-N Pretilachlor Chemical compound CCCOCCN(C(=O)CCl)C1=C(CC)C=CC=C1CC YLPGTOIOYRQOHV-UHFFFAOYSA-N 0.000 claims description 5
- ASRAWSBMDXVNLX-UHFFFAOYSA-N pyrazolynate Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)C=1C(C)=NN(C)C=1OS(=O)(=O)C1=CC=C(C)C=C1 ASRAWSBMDXVNLX-UHFFFAOYSA-N 0.000 claims description 5
- HKPHPIREJKHECO-UHFFFAOYSA-N butachlor Chemical compound CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC HKPHPIREJKHECO-UHFFFAOYSA-N 0.000 claims description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims 14
- 239000001530 fumaric acid Substances 0.000 claims 7
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 7
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims 4
- 239000005711 Benzoic acid Substances 0.000 claims 2
- 235000010233 benzoic acid Nutrition 0.000 claims 2
- OFSLKOLYLQSJPB-UHFFFAOYSA-N Cyclosulfamuron Chemical compound COC1=CC(OC)=NC(NC(=O)NS(=O)(=O)NC=2C(=CC=CC=2)C(=O)C2CC2)=N1 OFSLKOLYLQSJPB-UHFFFAOYSA-N 0.000 abstract description 5
- NNYRZQHKCHEXSD-UHFFFAOYSA-N Daimuron Chemical compound C1=CC(C)=CC=C1NC(=O)NC(C)(C)C1=CC=CC=C1 NNYRZQHKCHEXSD-UHFFFAOYSA-N 0.000 abstract description 5
- 240000007594 Oryza sativa Species 0.000 abstract description 5
- 235000007164 Oryza sativa Nutrition 0.000 abstract description 5
- 235000009566 rice Nutrition 0.000 abstract description 5
- SUSRORUBZHMPCO-UHFFFAOYSA-N MC-4379 Chemical compound C1=C([N+]([O-])=O)C(C(=O)OC)=CC(OC=2C(=CC(Cl)=CC=2)Cl)=C1 SUSRORUBZHMPCO-UHFFFAOYSA-N 0.000 abstract description 4
- CHNUNORXWHYHNE-UHFFFAOYSA-N Oxadiazon Chemical compound C1=C(Cl)C(OC(C)C)=CC(N2C(OC(=N2)C(C)(C)C)=O)=C1Cl CHNUNORXWHYHNE-UHFFFAOYSA-N 0.000 abstract description 4
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 abstract description 4
- HFEJHAAIJZXXRE-UHFFFAOYSA-N cafenstrole Chemical compound CCN(CC)C(=O)N1C=NC(S(=O)(=O)C=2C(=CC(C)=CC=2C)C)=N1 HFEJHAAIJZXXRE-UHFFFAOYSA-N 0.000 abstract description 4
- CHIFOSRWCNZCFN-UHFFFAOYSA-N pendimethalin Chemical compound CCC(CC)NC1=C([N+]([O-])=O)C=C(C)C(C)=C1[N+]([O-])=O CHIFOSRWCNZCFN-UHFFFAOYSA-N 0.000 abstract description 4
- 239000005484 Bifenox Substances 0.000 abstract description 3
- 239000005574 MCPA Substances 0.000 abstract description 3
- 239000005591 Pendimethalin Substances 0.000 abstract description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 abstract description 2
- 239000005588 Oxadiazon Substances 0.000 abstract description 2
- 150000002825 nitriles Chemical class 0.000 abstract description 2
- VTRWMTJQBQJKQH-UHFFFAOYSA-N pyributicarb Chemical compound COC1=CC=CC(N(C)C(=S)OC=2C=C(C=CC=2)C(C)(C)C)=N1 VTRWMTJQBQJKQH-UHFFFAOYSA-N 0.000 abstract description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 abstract 1
- UWVKRNOCDUPIDM-UHFFFAOYSA-N Ethoxysulfuron Chemical compound CCOC1=CC=CC=C1OS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 UWVKRNOCDUPIDM-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002474 experimental method Methods 0.000 description 43
- 238000002156 mixing Methods 0.000 description 32
- 239000013543 active substance Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000005507 spraying Methods 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- ZOMSMJKLGFBRBS-UHFFFAOYSA-N bentazone Chemical compound C1=CC=C2NS(=O)(=O)N(C(C)C)C(=O)C2=C1 ZOMSMJKLGFBRBS-UHFFFAOYSA-N 0.000 description 4
- 239000005476 Bentazone Substances 0.000 description 3
- WMLPCIHUFDKWJU-UHFFFAOYSA-N Cinosulfuron Chemical compound COCCOC1=CC=CC=C1S(=O)(=O)NC(=O)NC1=NC(OC)=NC(OC)=N1 WMLPCIHUFDKWJU-UHFFFAOYSA-N 0.000 description 3
- 241000234653 Cyperus Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- CNBGNNVCVSKAQZ-UHFFFAOYSA-N benzidamine Natural products C12=CC=CC=C2C(OCCCN(C)C)=NN1CC1=CC=CC=C1 CNBGNNVCVSKAQZ-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- PQTBTIFWAXVEPB-UHFFFAOYSA-N sulcotrione Chemical compound ClC1=CC(S(=O)(=O)C)=CC=C1C(=O)C1C(=O)CCCC1=O PQTBTIFWAXVEPB-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000005618 Sulcotrione Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- FHFJFSSWKDKHHG-UHFFFAOYSA-N butanoic acid;pyridine Chemical compound CCCC([O-])=O.C1=CC=[NH+]C=C1 FHFJFSSWKDKHHG-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- CIPHTOQKGSLCLV-UHFFFAOYSA-N n-phenylnaphthalene-1-carboxamide Chemical compound C=1C=CC2=CC=CC=C2C=1C(=O)NC1=CC=CC=C1 CIPHTOQKGSLCLV-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- WHOZNOZYMBRCBL-OUKQBFOZSA-N (2E)-2-Tetradecenal Chemical compound CCCCCCCCCCC\C=C\C=O WHOZNOZYMBRCBL-OUKQBFOZSA-N 0.000 description 1
- 241000219144 Abutilon Species 0.000 description 1
- 241000209136 Agropyron Species 0.000 description 1
- 235000011468 Albizia julibrissin Nutrition 0.000 description 1
- 241000748223 Alisma Species 0.000 description 1
- 241000743985 Alopecurus Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000219318 Amaranthus Species 0.000 description 1
- NXQDBZGWYSEGFL-UHFFFAOYSA-N Anilofos Chemical compound COP(=S)(OC)SCC(=O)N(C(C)C)C1=CC=C(Cl)C=C1 NXQDBZGWYSEGFL-UHFFFAOYSA-N 0.000 description 1
- 241001666377 Apera Species 0.000 description 1
- 235000005781 Avena Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000611157 Brachiaria Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 241000209200 Bromus Species 0.000 description 1
- 241000320316 Carduus Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 235000017896 Digitaria Nutrition 0.000 description 1
- 241001303487 Digitaria <clam> Species 0.000 description 1
- 241000192043 Echinochloa Species 0.000 description 1
- 241000169203 Eichhornia Species 0.000 description 1
- 241000202829 Eleocharis Species 0.000 description 1
- 235000007351 Eleusine Nutrition 0.000 description 1
- 241000209215 Eleusine Species 0.000 description 1
- 241000748465 Galinsoga Species 0.000 description 1
- 241001101998 Galium Species 0.000 description 1
- 241000169108 Hydrothrix Species 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 241001327265 Ischaemum Species 0.000 description 1
- 241000520028 Lamium Species 0.000 description 1
- 241000209510 Liliopsida Species 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- 241000064140 Lindernia Species 0.000 description 1
- 241000209082 Lolium Species 0.000 description 1
- 235000017945 Matricaria Nutrition 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 240000005852 Mimosa quadrivalvis Species 0.000 description 1
- 235000003990 Monochoria hastata Nutrition 0.000 description 1
- 240000000178 Monochoria vaginalis Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000209117 Panicum Species 0.000 description 1
- 235000006443 Panicum miliaceum subsp. miliaceum Nutrition 0.000 description 1
- 235000009037 Panicum miliaceum subsp. ruderale Nutrition 0.000 description 1
- 241000209048 Poa Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- 241000722195 Potamogeton Species 0.000 description 1
- BGNQYGRXEXDAIQ-UHFFFAOYSA-N Pyrazosulfuron-ethyl Chemical group C1=NN(C)C(S(=O)(=O)NC(=O)NC=2N=C(OC)C=C(OC)N=2)=C1C(=O)OCC BGNQYGRXEXDAIQ-UHFFFAOYSA-N 0.000 description 1
- 241000341978 Rotala Species 0.000 description 1
- 240000009132 Sagittaria sagittifolia Species 0.000 description 1
- 241000202758 Scirpus Species 0.000 description 1
- 241000780602 Senecio Species 0.000 description 1
- 244000275012 Sesbania cannabina Species 0.000 description 1
- 235000005775 Setaria Nutrition 0.000 description 1
- 241000232088 Setaria <nematode> Species 0.000 description 1
- 241000220261 Sinapis Species 0.000 description 1
- 241000207763 Solanum Species 0.000 description 1
- 235000002634 Solanum Nutrition 0.000 description 1
- 241000488874 Sonchus Species 0.000 description 1
- 240000006694 Stellaria media Species 0.000 description 1
- 241000219422 Urtica Species 0.000 description 1
- 240000005592 Veronica officinalis Species 0.000 description 1
- 241000405217 Viola <butterfly> Species 0.000 description 1
- 241001506766 Xanthium Species 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- 150000008107 benzenesulfonic acids Chemical class 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- RYAGRZNBULDMBW-UHFFFAOYSA-L calcium;3-(2-hydroxy-3-methoxyphenyl)-2-[2-methoxy-4-(3-sulfonatopropyl)phenoxy]propane-1-sulfonate Chemical compound [Ca+2].COC1=CC=CC(CC(CS([O-])(=O)=O)OC=2C(=CC(CCCS([O-])(=O)=O)=CC=2)OC)=C1O RYAGRZNBULDMBW-UHFFFAOYSA-L 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- OKISBDHRUPZLOC-UHFFFAOYSA-N gallin Chemical compound OC(=O)C1=CC=CC=C1C1C2=CC=C(O)C(O)=C2OC2=C(O)C(O)=CC=C21 OKISBDHRUPZLOC-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229950006942 hamycin Drugs 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 229940044654 phenolsulfonic acid Drugs 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19544393A DE19544393A1 (de) | 1995-11-15 | 1995-11-15 | Synergistische herbizide Mischungen |
| DE19544393.4 | 1995-11-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR19990067314A KR19990067314A (ko) | 1999-08-16 |
| KR100427960B1 true KR100427960B1 (ko) | 2005-01-15 |
Family
ID=7778639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR10-1998-0703305A Expired - Lifetime KR100427960B1 (ko) | 1995-11-15 | 1996-11-12 | 상승 작용성 제초제 혼합물 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6013605A (enExample) |
| EP (1) | EP0863705B1 (enExample) |
| JP (1) | JP3920341B2 (enExample) |
| KR (1) | KR100427960B1 (enExample) |
| CN (1) | CN1084148C (enExample) |
| AU (1) | AU711841B2 (enExample) |
| BR (1) | BR9611478A (enExample) |
| CA (1) | CA2236592C (enExample) |
| DE (2) | DE19544393A1 (enExample) |
| ES (1) | ES2178720T3 (enExample) |
| MX (1) | MX9803824A (enExample) |
| MY (1) | MY114731A (enExample) |
| RU (1) | RU2170017C2 (enExample) |
| TR (1) | TR199800794T2 (enExample) |
| TW (1) | TW355125B (enExample) |
| UA (1) | UA48203C2 (enExample) |
| WO (1) | WO1997017852A1 (enExample) |
| ZA (1) | ZA969564B (enExample) |
Families Citing this family (255)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19836684A1 (de) | 1998-08-13 | 2000-02-17 | Hoechst Schering Agrevo Gmbh | Herbizide Mittel für tolerante oder resistente Reiskulturen |
| KR100338621B1 (ko) * | 2000-01-24 | 2002-05-30 | 전광술 | 제초제 및 그 제조방법 |
| US20070160576A1 (en) | 2001-06-05 | 2007-07-12 | Genentech, Inc. | IL-17A/F heterologous polypeptides and therapeutic uses thereof |
| KR100788092B1 (ko) | 2001-06-20 | 2007-12-21 | 제넨테크, 인크. | 종양의 진단 및 치료를 위한 방법 및 이를 위한 조성물 |
| EP1420644B1 (de) | 2001-08-23 | 2006-05-31 | Bayer CropScience S.A. | Substituierte propargylamine |
| MXPA04002593A (es) | 2001-09-18 | 2004-05-31 | Genentech Inc | Composiciones y metodos para el diagnostico y tratamiento de tumor. |
| KR100623128B1 (ko) | 2002-01-02 | 2006-09-14 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
| KR100429139B1 (ko) * | 2002-02-28 | 2004-04-29 | 한국화학연구원 | 싸이할로호프와 메타미호프를 유효성분으로 하는 제초제조성물 및 이를 이용하여 화본과 잡초를 방제하는 방법 |
| KR20040101502A (ko) | 2002-04-16 | 2004-12-02 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
| EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
| HRP20050934B1 (hr) | 2003-04-04 | 2014-09-26 | Genentech, Inc. | Formulacije s visokom koncentracijom antitijela i proteina |
| US6849579B2 (en) * | 2003-06-25 | 2005-02-01 | Pbi Gordon Corporation | Synergistic quinclorac herbicidal compositions |
| MX341074B (es) | 2003-07-08 | 2016-08-05 | Genentech Inc | Polipeptidos heterologos il-17 a/f y usos terapeuticos de los mismos. |
| DE602004024921D1 (de) | 2003-11-17 | 2010-02-11 | Genentech Inc | Zusammensetzungen und verfahren zur behandlung von tumoren hämatopoetischen ursprungs |
| JP4570890B2 (ja) * | 2004-03-26 | 2010-10-27 | 協友アグリ株式会社 | 除草剤組成物 |
| US20060051347A1 (en) | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| CN102580084B (zh) | 2005-01-21 | 2016-11-23 | 健泰科生物技术公司 | Her抗体的固定剂量给药 |
| MX2007009889A (es) | 2005-02-23 | 2007-09-07 | Genentech Inc | Alargar el tiempo hasta la progresion de la enfermedad o la supervivencia de los pacientes de cancer. |
| US20090136505A1 (en) | 2005-02-23 | 2009-05-28 | Johanna Bentz | Intranasal Administration of Active Agents to the Central Nervous System |
| MX2007010244A (es) | 2005-02-23 | 2008-03-10 | Johnson & Johnson | Administracion intranasal de agentes activos al sistema nervioso central. |
| CA2598833A1 (en) | 2005-03-03 | 2006-09-08 | Curt W. Bradshaw | Anti-angiogenic compounds |
| AU2006255686A1 (en) | 2005-06-06 | 2006-12-14 | Genentech, Inc. | Transgenic models for different genes and their use for gene characterization |
| EP1922410A2 (en) | 2005-08-15 | 2008-05-21 | Genentech, Inc. | Gene disruptions, compositions and methods relating thereto |
| JP2009516514A (ja) | 2005-11-21 | 2009-04-23 | ジェネンテック・インコーポレーテッド | 新規遺伝子破壊、それらに関する組成物および方法 |
| EP1988768A2 (en) | 2006-02-17 | 2008-11-12 | Genentech, Inc. | Gene disruptions, compositions and methods relating thereto |
| EP1989231B1 (en) | 2006-03-21 | 2015-05-20 | Genentech, Inc. | Combinatorial therapy involving alpha5beta1 antagonists |
| CA2647277A1 (en) | 2006-04-05 | 2007-11-08 | Genentech, Inc. | Method for using boc/cdo to modulate hedgehog signaling |
| EP2082645A1 (en) | 2006-04-19 | 2009-07-29 | Genentech, Inc. | Novel gene disruptions, compositions and methods relating thereto |
| CL2007001623A1 (es) | 2006-06-06 | 2008-01-18 | Genentech Inc | Anticuerpo anti-dll4; polinucleotido que lo codifica; vector y celula huesped que comprenden dicho polinucleotido; metodo para elaborar el anticuerpo e inmunojugado; metodo de deteccion de dll4 y metodo diagnostico de un trastorno asociado a dll4; composicion que comprende al anticuerpo. |
| US8874380B2 (en) | 2010-12-09 | 2014-10-28 | Rutgers, The State University Of New Jersey | Method of overcoming therapeutic limitations of nonuniform distribution of radiopharmaceuticals and chemotherapy drugs |
| CA2660286A1 (en) | 2006-08-09 | 2008-02-21 | Homestead Clinical Corporation | Organ-specific proteins and methods of their use |
| PL2059533T3 (pl) | 2006-08-30 | 2013-04-30 | Genentech Inc | Przeciwciała wieloswoiste |
| NZ576751A (en) | 2006-11-10 | 2011-10-28 | Covx Technologies Ireland Ltd | Anti-angiogenic compounds |
| JP5761915B2 (ja) | 2007-02-22 | 2015-08-12 | ジェネンテック， インコーポレイテッド | 炎症性腸疾患の検出方法 |
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| CA3006428A1 (en) | 2007-06-08 | 2008-12-18 | Genentech, Inc. | Gene expression markers of tumor resistance to her2 inhibitor treatment |
| ES2528922T3 (es) | 2007-07-16 | 2015-02-13 | Genentech, Inc. | Anticuerpos anti-CD79b humanizados e inmunoconjugados y métodos de uso |
| RS53595B1 (sr) | 2007-07-16 | 2015-02-27 | Genentech, Inc. | Anti-cd79b antitela i imunokonjugati i metode upotrebe |
| KR101620642B1 (ko) | 2007-11-07 | 2016-05-12 | 제넨테크, 인크. | 항-ｃｄ４０ 항체를 사용한 치료에 대한 ｂ-세포 림프종의 반응성 평가를 위한 방법 및 조성물 |
| MX2010005244A (es) | 2007-11-12 | 2010-10-25 | Theraclone Sciences Inc | Composiciones y métodos para la terapia y el diagnóstico de influenza. |
| WO2010135521A2 (en) | 2009-05-20 | 2010-11-25 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| IL287292B (en) | 2008-01-31 | 2022-09-01 | Genentech Inc | Cycteine engineering anti-cd79b antibodies and antibody-drug conjugates |
| EP2257571B1 (en) | 2008-03-10 | 2015-03-04 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of cytomegalovirus infections |
| CN102232113A (zh) | 2008-03-31 | 2011-11-02 | 健泰科生物技术公司 | 用于治疗和诊断哮喘的组合物和方法 |
| SI2279004T1 (sl) | 2008-05-16 | 2015-05-29 | F. Hoffmann-La Roche Ag | Uporaba biomarkerjev za ocenjevanje zdravljenja gastrointestinalnih vnetnih motenj z antagonisti beta7 integrina |
| CA2729306C (en) | 2008-07-08 | 2015-08-18 | Oncomed Pharmaceuticals, Inc. | Notch-binding agents and antagonists and methods of use thereof |
| EP2318832B1 (en) | 2008-07-15 | 2013-10-09 | Academia Sinica | Glycan arrays on ptfe-like aluminum coated glass slides and related methods |
| CN101352171B (zh) * | 2008-09-19 | 2012-07-04 | 北京燕化永乐农药有限公司 | 吡嘧磺隆与甲羧除草醚农药的除草剂组合物 |
| CA3019967A1 (en) | 2008-11-13 | 2010-05-20 | The General Hospital Corporation | Methods and compositions for regulating iron homeostasis by modulation of bmp-6 |
| US8211434B2 (en) | 2008-11-26 | 2012-07-03 | Allergan, Inc. | KLK-13 antibody inhibitor for treating dry eye |
| US8217149B2 (en) | 2008-12-09 | 2012-07-10 | Genentech, Inc. | Anti-PD-L1 antibodies, compositions and articles of manufacture |
| SI3260136T1 (sl) | 2009-03-17 | 2021-05-31 | Theraclone Sciences, Inc. | Humani imunodeficientni virus (HIV)-nevtralizirajoča protitelesa |
| AR075896A1 (es) | 2009-03-20 | 2011-05-04 | Genentech Inc | Anticuerpos anti-her (factor de crecimiento epidermico) |
| WO2010114859A1 (en) | 2009-04-01 | 2010-10-07 | Genentech, Inc. | Treatment of insulin-resistant disorders |
| WO2010120561A1 (en) | 2009-04-01 | 2010-10-21 | Genentech, Inc. | Anti-fcrh5 antibodies and immunoconjugates and methods of use |
| WO2010118243A2 (en) | 2009-04-08 | 2010-10-14 | Genentech, Inc. | Use of il-27 antagonists to treat lupus |
| ES2605228T3 (es) | 2009-04-18 | 2017-03-13 | Genentech, Inc. | Métodos para evaluar la capacidad de respuesta de un linfoma de células B al tratamiento con anticuerpos anti-CD40 |
| CA2759506A1 (en) | 2009-04-23 | 2010-10-28 | Theraclone Sciences, Inc. | Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies |
| US20110038871A1 (en) | 2009-08-11 | 2011-02-17 | Veena Viswanth | Ccr2 inhibitors for treating conditions of the eye |
| BR112012009409A2 (pt) | 2009-10-22 | 2017-02-21 | Genentech Inc | método de identificação de uma substância inibidora, molécula antagonista, ácido nucleico isolado, vetor, célula hospedeira, método para fabricar a molécula, composição, artigo de fabricação, método de inibição de uma atividade biológica, método de tratamento de uma condição patológica, método para detectar msp em uma amostra e método para detectar hepsina em uma amostra |
| WO2011056497A1 (en) | 2009-10-26 | 2011-05-12 | Genentech, Inc. | Activin receptor type iib compositions and methods of use |
| WO2011056494A1 (en) | 2009-10-26 | 2011-05-12 | Genentech, Inc. | Activin receptor-like kinase-1 antagonist and vegfr3 antagonist combinations |
| HUE033492T2 (en) | 2009-10-26 | 2017-12-28 | Genentech Inc | Tests for the detection of antibodies specific for therapeutic anti-verb antibodies and their use in anaphylaxis |
| WO2011056502A1 (en) | 2009-10-26 | 2011-05-12 | Genentech, Inc. | Bone morphogenetic protein receptor type ii compositions and methods of use |
| TWI507524B (zh) | 2009-11-30 | 2015-11-11 | Genentech Inc | 診斷及治療腫瘤之組合物及方法 |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| WO2011082187A1 (en) | 2009-12-30 | 2011-07-07 | Genentech, Inc. | Methods for modulating a pdgf-aa mediated biological response |
| MA34057B1 (fr) | 2010-02-23 | 2013-03-05 | Genentech Inc | Compositions et methodes pour le diagnostic et le traitement d'une tumeur |
| WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| WO2011133931A1 (en) | 2010-04-22 | 2011-10-27 | Genentech, Inc. | Use of il-27 antagonists for treating inflammatory bowel disease |
| RU2012151500A (ru) | 2010-05-03 | 2014-06-10 | Дженентек, Инк. | Композиции и способы, пригодные для снижения вязкости белковосодержащих составов |
| DK2568976T3 (en) | 2010-05-10 | 2016-01-11 | Academia Sinica | Zanamivir-phosphonate congener with the anti-influenza activity, and determining the sensitivity oseltamivir in influenza viruses |
| CN102265853A (zh) * | 2010-06-04 | 2011-12-07 | 南京华洲药业有限公司 | 一种含灭草松和二氯喹啉酸的除草组合物及其应用 |
| US20110311527A1 (en) | 2010-06-16 | 2011-12-22 | Allergan, Inc. | IL23p19 ANTIBODY INHIBITOR FOR TREATING OCULAR AND OTHER CONDITIONS |
| EP2603237A4 (en) | 2010-08-12 | 2014-05-21 | Theraclone Sciences Inc | ANTI-HEMAGGLUTININE ANTIBODY COMPOSITIONS AND METHOD FOR THEIR USE |
| EP2420250A1 (en) | 2010-08-13 | 2012-02-22 | Universitätsklinikum Münster | Anti-Syndecan-4 antibodies |
| AU2011288412A1 (en) | 2010-08-13 | 2013-02-21 | Medimmune Limited | Monomeric polypeptides comprising variant Fc regions and methods of use |
| WO2012022734A2 (en) | 2010-08-16 | 2012-02-23 | Medimmune Limited | Anti-icam-1 antibodies and methods of use |
| EP4549461A3 (en) | 2010-08-31 | 2025-08-06 | Theraclone Sciences, Inc. | Human immunodeficiency virus (hiv)-neutralizing antibodies |
| WO2012092539A2 (en) | 2010-12-31 | 2012-07-05 | Takeda Pharmaceutical Company Limited | Antibodies to dll4 and uses thereof |
| CA2827301A1 (en) | 2011-02-14 | 2012-08-23 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| SG193402A1 (en) | 2011-03-15 | 2013-10-30 | Theraclone Sciences Inc | Compositions and methods for the therapy and diagnosis of influenza |
| AU2012236304C1 (en) | 2011-03-31 | 2017-01-05 | Genentech, Inc. | Methods of administering beta7 integrin antagonists |
| BR122020001787A8 (pt) | 2011-05-08 | 2023-04-25 | Legochem Biosciences Inc | Conjugado de anticorpo-agente ativo, seus métodos de preparação, sua composição e seu uso |
| HUE053545T2 (hu) | 2011-05-17 | 2021-07-28 | Univ Rockefeller | Humán immundeficiencia vírus semlegesítõ antitestek és eljárások alkalmazásukra |
| JP6305919B2 (ja) | 2011-06-06 | 2018-04-04 | プロセナ バイオサイエンシーズ リミテッド | Ｍｃａｍアンタゴニスト及び治療の方法 |
| JP2013040160A (ja) | 2011-07-01 | 2013-02-28 | Genentech Inc | 自己免疫疾患を治療するための抗ｃｄ８３アゴニスト抗体の使用 |
| US9120858B2 (en) | 2011-07-22 | 2015-09-01 | The Research Foundation Of State University Of New York | Antibodies to the B12-transcobalamin receptor |
| WO2013015821A1 (en) | 2011-07-22 | 2013-01-31 | The Research Foundation Of State University Of New York | Antibodies to the b12-transcobalamin receptor |
| WO2013016468A2 (en) | 2011-07-25 | 2013-01-31 | California Institute Of Technology | Compositions and methods for improving potency and breadth or hiv antibodies |
| US9493549B2 (en) | 2011-07-25 | 2016-11-15 | The Rockefeller University | Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth |
| WO2013033069A1 (en) | 2011-08-30 | 2013-03-07 | Theraclone Sciences, Inc. | Human rhinovirus (hrv) antibodies |
| CA2862979A1 (en) | 2012-01-09 | 2013-07-18 | The Scripps Research Institute | Humanized antibodies with ultralong cdr3s |
| JP6684490B2 (ja) | 2012-01-09 | 2020-04-22 | ザ・スクリップス・リサーチ・インスティテュート | 超長相補性決定領域及びその使用 |
| TW201334789A (zh) | 2012-01-31 | 2013-09-01 | Genentech Inc | 抗ｉｇｅ抗體及其使用方法 |
| CA2865082A1 (en) | 2012-03-27 | 2013-10-03 | Genentech, Inc. | Diagnosis and treatments relating to her3 inhibitors |
| EP3725892A1 (en) | 2012-03-27 | 2020-10-21 | F. Hoffmann-La Roche AG | Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| US9879068B2 (en) | 2012-06-21 | 2018-01-30 | California Institute Of Technology | Antibodies targeting HIV escape mutants |
| WO2014018375A1 (en) | 2012-07-23 | 2014-01-30 | Xenon Pharmaceuticals Inc. | Cyp8b1 and uses thereof in therapeutic and diagnostic methods |
| EP2885311B1 (en) | 2012-08-18 | 2020-01-01 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| US9547009B2 (en) | 2012-08-21 | 2017-01-17 | Academia Sinica | Benzocyclooctyne compounds and uses thereof |
| TWI660972B (zh) | 2012-09-10 | 2019-06-01 | 愛爾蘭商尼歐托普生物科學公司 | 抗ｍｃａｍ抗體及相關使用方法 |
| MX372664B (es) | 2012-10-05 | 2020-05-06 | Genentech Inc | Un antagonista de integrina beta7 para usarse en diagnosticar y tratar la enfermedad inflamatoria intestinal. |
| WO2014063059A1 (en) | 2012-10-18 | 2014-04-24 | Rockefeller University (The) | Broadly-neutralizing anti-hiv antibodies |
| WO2014063205A1 (en) | 2012-10-26 | 2014-05-01 | The University Of Queensland | Use of endocytosis inhibitors and antibodies for cancer therapy |
| EP3495814A3 (en) | 2013-03-27 | 2019-07-17 | F. Hoffmann-La Roche AG | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7 integrin antagonists |
| US20160053023A1 (en) | 2013-04-09 | 2016-02-25 | Annexon, Inc. | Methods of treatment for neuromyelitis optica |
| US10086054B2 (en) | 2013-06-26 | 2018-10-02 | Academia Sinica | RM2 antigens and use thereof |
| US9981030B2 (en) | 2013-06-27 | 2018-05-29 | Academia Sinica | Glycan conjugates and use thereof |
| SI3019240T1 (sl) | 2013-07-09 | 2024-07-31 | Annexon, Inc. | Protitelesa proti komplementnemu faktorju C1q in njihova uporaba |
| WO2015017146A2 (en) | 2013-07-18 | 2015-02-05 | Fabrus, Inc. | Antibodies with ultralong complementarity determining regions |
| CN105814074B (zh) | 2013-07-18 | 2020-04-21 | 图鲁斯生物科学有限责任公司 | 具有超长互补决定区的人源化抗体 |
| WO2015035337A1 (en) | 2013-09-06 | 2015-03-12 | Academia Sinica | HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS WITH ALTERED GLYCOSYL GROUPS |
| WO2015050959A1 (en) | 2013-10-01 | 2015-04-09 | Yale University | Anti-kit antibodies and methods of use thereof |
| CN105849124B (zh) | 2013-12-20 | 2022-04-12 | 豪夫迈·罗氏有限公司 | 双重特异性抗体 |
| EP3094654B1 (en) | 2014-01-14 | 2020-03-11 | The Medical College of Wisconsin, Inc. | Targeting clptm1l for treatment and prevention of cancer |
| US9982041B2 (en) | 2014-01-16 | 2018-05-29 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| WO2015116902A1 (en) | 2014-01-31 | 2015-08-06 | Genentech, Inc. | G-protein coupled receptors in hedgehog signaling |
| EP3129767B1 (en) | 2014-03-27 | 2021-09-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| SG11201607938UA (en) | 2014-03-27 | 2016-10-28 | Genentech Inc | Methods for diagnosing and treating inflammatory bowel disease |
| CN104012547A (zh) * | 2014-05-07 | 2014-09-03 | 广东中迅农科股份有限公司 | 一种含有双唑草腈和氰氟草酯的除草组合物 |
| CN104012549B (zh) * | 2014-05-07 | 2016-08-17 | 广东中迅农科股份有限公司 | 一种含有双唑草腈和双草醚的除草组合物 |
| WO2015175874A2 (en) | 2014-05-16 | 2015-11-19 | Medimmune, Llc | Molecules with altered neonate fc receptor binding having enhanced therapeutic and diagnostic properties |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| AU2015267051B2 (en) | 2014-05-27 | 2022-03-17 | Academia Sinica | Fucosidase from bacteroides and methods using the same |
| CN106573971A (zh) | 2014-05-27 | 2017-04-19 | 中央研究院 | 抗cd20醣抗体及其用途 |
| CA2950440A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Anti-her2 glycoantibodies and uses thereof |
| CN106714829A (zh) | 2014-05-28 | 2017-05-24 | 中央研究院 | 抗TNF‑α醣抗体及其用途 |
| AU2015266664B2 (en) | 2014-05-30 | 2020-04-30 | Shanghai Henlius Biotech, Inc. | Anti-epidermal growth factor receptor (EGFR) antibodies |
| MX2017001531A (es) | 2014-08-08 | 2017-05-15 | Alector Llc | Anticuerpos anti-trem2 y metodos de uso de los mismos. |
| US9879042B2 (en) | 2014-09-08 | 2018-01-30 | Academia Sinica | Human iNKT cell activation using glycolipids |
| CN104255750A (zh) * | 2014-09-10 | 2015-01-07 | 广东中迅农科股份有限公司 | 含有双唑草腈和丙草胺的除草组合物 |
| WO2016073157A1 (en) | 2014-11-06 | 2016-05-12 | Genentech, Inc. | Anti-ang2 antibodies and methods of use thereof |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| CN107427004B (zh) | 2015-01-22 | 2021-06-08 | 巴斯夫农业公司 | 包含苯嘧磺草胺的三元除草组合 |
| AU2015378564A1 (en) | 2015-01-24 | 2017-07-13 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| JP2018506275A (ja) | 2015-01-28 | 2018-03-08 | ジェネンテック， インコーポレイテッド | 多発性硬化症の遺伝子発現マーカー及び治療 |
| EP3262072A1 (en) | 2015-02-26 | 2018-01-03 | F. Hoffmann-La Roche AG | Integrin beta7 antagonists and methods of treating crohn's disease |
| RU2021124437A (ru) | 2015-04-03 | 2021-09-29 | Еурека Терапьютикс, Инк. | Конструкции, направленные на комплексы пептида afp/mhc, и виды их использования |
| JP6999421B2 (ja) | 2015-04-07 | 2022-02-04 | アレクトル エルエルシー | 抗ソルチリン抗体及びその使用方法 |
| CN104757013A (zh) * | 2015-04-18 | 2015-07-08 | 广东中迅农科股份有限公司 | 含有双唑草腈和四唑酰草胺及精噁唑禾草灵的除草组合物 |
| WO2016191811A1 (en) | 2015-06-03 | 2016-12-08 | The University Of Queensland | Mobilizing agents and uses therefor |
| WO2016201389A2 (en) | 2015-06-12 | 2016-12-15 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| AU2016276981B2 (en) | 2015-06-12 | 2022-10-06 | Alector Llc | Anti-CD33 antibodies and methods of use thereof |
| EA201890260A1 (ru) | 2015-07-10 | 2018-07-31 | Басф Агро Б.В. | Гербицидная композиция, содержащая цинметилин и пироксасульфон |
| BR112018000482B1 (pt) | 2015-07-10 | 2022-11-22 | BASF Agro B.V. | Composição herbicida, uso da composição e método para o controle da vegetação indesejada |
| PL3319434T3 (pl) | 2015-07-10 | 2019-11-29 | Basf Agro Bv | Kompozycja chwastobójcza zawierająca cynmetylinę i petoksamid |
| US11219212B2 (en) | 2015-07-10 | 2022-01-11 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and imazamox |
| AU2016292569B2 (en) | 2015-07-10 | 2021-01-21 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and specific pigment synthesis inhibitors |
| WO2017009056A1 (en) | 2015-07-10 | 2017-01-19 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and dimethenamid |
| EA201890270A1 (ru) | 2015-07-10 | 2018-08-31 | Басф Агро Б.В. | Гербицидная композиция, которая содержит цинметилин и специфические хинолинкарбоновые кислоты |
| WO2017009140A1 (en) | 2015-07-10 | 2017-01-19 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and acetochlor or pretilachlor |
| US11219215B2 (en) | 2015-07-10 | 2022-01-11 | BASF Agro B.V. | Herbicidal composition comprising cinmethylin and specific inhibitors of protoporphyrinogen oxidase |
| EP3319442B1 (en) | 2015-07-10 | 2021-09-29 | BASF Agro B.V. | Method for controlling herbicide resistant or tolerant weeds |
| CN105076162B (zh) * | 2015-08-05 | 2018-03-09 | 安徽华星化工有限公司 | 一种含有乙氧氟草醚和双唑草腈的水稻田除草组合物 |
| WO2017040301A1 (en) | 2015-08-28 | 2017-03-09 | Alector Llc | Anti-siglec-7 antibodies and methods of use thereof |
| JP7725185B2 (ja) | 2015-10-06 | 2025-08-19 | アレクトル エルエルシー | 抗ｔｒｅｍ２抗体及びその使用方法 |
| MX2018004721A (es) | 2015-10-23 | 2018-07-06 | Eureka Therapeutics Inc | Construcciones quimericas anticuerpo/receptor de celulas t y usos de las mismas. |
| KR20180084817A (ko) | 2015-10-29 | 2018-07-25 | 알렉터 엘엘씨 | 항-siglec-9 항체 및 이의 이용 방법 |
| CN112451682A (zh) | 2015-11-25 | 2021-03-09 | 乐高化学生物科学股份有限公司 | 包含自降解基团的缀合物及其相关方法 |
| AU2016380988B2 (en) | 2015-12-30 | 2022-07-21 | Genentech, Inc. | Formulations with reduced degradation of polysorbate |
| US11472877B2 (en) | 2016-03-04 | 2022-10-18 | Alector Llc | Anti-TREM1 antibodies and methods of use thereof |
| KR20180114210A (ko) | 2016-03-08 | 2018-10-17 | 아카데미아 시니카 | N-글리칸의 모듈 합성 방법 및 그의 어레이 |
| CN105901005A (zh) * | 2016-05-16 | 2016-08-31 | 河北博嘉农业有限公司 | 一种含有双唑草腈的除草组合物 |
| CN105918339A (zh) * | 2016-05-19 | 2016-09-07 | 河北博嘉农业有限公司 | 一种含有双唑草腈和磺酰脲类除草剂的除草组合物 |
| WO2018014260A1 (en) | 2016-07-20 | 2018-01-25 | Nanjing Legend Biotech Co., Ltd. | Multispecific antigen binding proteins and methods of use thereof |
| US10538592B2 (en) | 2016-08-22 | 2020-01-21 | Cho Pharma, Inc. | Antibodies, binding fragments, and methods of use |
| BR112019005129A2 (pt) | 2016-09-16 | 2019-06-04 | Shanghai Henlius Biotech, Inc. | anticorpos anti-pd-1 |
| WO2018068201A1 (en) | 2016-10-11 | 2018-04-19 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies and variants thereof against ctla-4 |
| CN108064865A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN106561695A (zh) * | 2016-11-15 | 2017-04-19 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064868A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064866A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064871A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| CN108064860A (zh) * | 2016-11-15 | 2018-05-25 | 江苏龙灯化学有限公司 | 一种除草组合物 |
| KR102085798B1 (ko) | 2016-12-28 | 2020-03-06 | 주식회사 인투셀 | 베타-갈락토사이드가 도입된 자가-희생 기를 포함하는 화합물 |
| TW201831517A (zh) | 2017-01-12 | 2018-09-01 | 美商優瑞科生物技術公司 | 靶向組織蛋白h3肽/mhc複合體之構築體及其用途 |
| WO2018152496A1 (en) | 2017-02-17 | 2018-08-23 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Compositions and methods for the diagnosis and treatment of zika virus infection |
| CN107047594A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与氯吡嘧磺隆的除草组合物及其应用 |
| CN106857576A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与苯噻酰草胺的除草组合物及其应用 |
| CN106857578A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与乙草胺的除草组合物及其应用 |
| CN106857600A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与异丙隆的除草组合物及其应用 |
| CN106857579A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与三嗪氟草胺的除草组合物及其应用 |
| CN106857621A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与禾草敌的除草组合物及其应用 |
| CN107047582A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与禾草畏的除草组合物及其应用 |
| CN106857575A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与丁草胺的除草组合物及其应用 |
| CN106857577A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与氟硫草定的除草组合物及其应用 |
| CN107047593A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与乙氧磺隆的除草组合物及其应用 |
| CN106857580A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与吡氟酰草胺的除草组合物及其应用 |
| CN106857609A (zh) * | 2017-02-27 | 2017-06-20 | 南京华洲药业有限公司 | 一种含双唑草腈与乙氧嘧磺隆的除草组合物及其应用 |
| CN106889082A (zh) * | 2017-02-27 | 2017-06-27 | 南京华洲药业有限公司 | 一种含双唑草腈与噁草酮的除草组合物及其应用 |
| CN106889084A (zh) * | 2017-02-27 | 2017-06-27 | 南京华洲药业有限公司 | 一种含双唑草腈与灭草松的除草组合物及其应用 |
| CN106889094A (zh) * | 2017-02-27 | 2017-06-27 | 南京华洲药业有限公司 | 一种含双唑草腈与吡嘧磺隆的除草组合物及其应用 |
| CN106889083B (zh) * | 2017-02-27 | 2019-02-12 | 南京华洲药业有限公司 | 一种含双唑草腈与异恶草酮的除草组合物及其应用 |
| CN107047578A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与丙炔噁草酮的除草组合物及其应用 |
| CN107047592A (zh) * | 2017-02-27 | 2017-08-18 | 南京华洲药业有限公司 | 一种含双唑草腈与苄嘧磺隆的除草组合物及其应用 |
| RU2665790C1 (ru) | 2017-04-17 | 2018-09-04 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело к pd-l1 |
| EP3615569A1 (en) | 2017-04-25 | 2020-03-04 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Antibodies and methods for the diagnosis and treatment of epstein barr virus infection |
| AU2018258045B2 (en) | 2017-04-26 | 2024-02-29 | Eureka Therapeutics, Inc. | Chimeric antibody/T-cell receptor constructs and uses thereof |
| AU2018258049B2 (en) | 2017-04-26 | 2025-03-27 | Eureka Therapeutics, Inc. | Constructs specifically recognizing glypican 3 and uses thereof |
| US11359014B2 (en) | 2017-05-16 | 2022-06-14 | Alector Llc | Anti-siglec-5 antibodies and methods of use thereof |
| CN107114382A (zh) * | 2017-05-22 | 2017-09-01 | 娄天成 | 一种含双唑草腈和敌稗的农药组合物及其应用 |
| CN106954634A (zh) * | 2017-05-22 | 2017-07-18 | 娄天成 | 一种含双唑草腈和莎稗磷的农药组合物及其应用 |
| CN107094781A (zh) * | 2017-05-22 | 2017-08-29 | 孙金金 | 一种含双唑草腈和二氯喹啉酸的农药组合物及其应用 |
| WO2018215535A1 (en) | 2017-05-23 | 2018-11-29 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Novel cd73 antibody, preparation and uses thereof |
| CN107006498A (zh) * | 2017-05-24 | 2017-08-04 | 江苏省农用激素工程技术研究中心有限公司 | 用于防除稻田杂草的除草组合物 |
| RU2653545C1 (ru) * | 2017-07-17 | 2018-05-11 | АО "Щелково Агрохим" | Гербицидная композиция на основе бентазона для защиты зернобобовых культур |
| EP3655430A1 (en) | 2017-07-19 | 2020-05-27 | The U.S.A. as represented by the Secretary, Department of Health and Human Services | Antibodies and methods for the diagnosis and treatment of hepatitis b virus infection |
| RS64419B1 (sr) | 2017-08-03 | 2023-09-29 | Alector Llc | Anti-trem2 antitela i postupci za njihovu upotrebu |
| CN110662765B (zh) | 2017-08-03 | 2023-09-29 | 艾利妥 | 抗cd33抗体及其使用方法 |
| EA039662B1 (ru) | 2017-10-03 | 2022-02-24 | Закрытое Акционерное Общество "Биокад" | Антитела, специфичные к cd47 и pd-l1 |
| RU2698048C2 (ru) | 2017-10-03 | 2019-08-21 | Закрытое Акционерное Общество "Биокад" | МОНОКЛОНАЛЬНОЕ АНТИТЕЛО К IL-5Rα |
| MX2020006372A (es) | 2017-12-19 | 2020-09-03 | Univ Rockefeller | Variantes de dominio de fc de igg humana con funcion efectora mejorada. |
| JP7369127B2 (ja) | 2017-12-28 | 2023-10-25 | ナンジン レジェンド バイオテック カンパニー，リミテッド | Ｔｉｇｉｔに対する単一ドメイン抗体及びその変異体 |
| KR20250114571A (ko) | 2018-01-15 | 2025-07-29 | 난징 레전드 바이오테크 씨오., 엘티디. | Pd-1에 대한 단일-도메인 항체 및 이의 변이체 |
| WO2019145475A2 (en) | 2018-01-25 | 2019-08-01 | Acm Biolabs Pte Ltd | Polymersomes comprising a soluble encapsulated antigen as well as methods of making and uses thereof |
| CN108371183A (zh) * | 2018-02-02 | 2018-08-07 | 河北中天邦正生物科技股份公司 | 一种农药组合物及其应用 |
| CN108308187A (zh) * | 2018-02-11 | 2018-07-24 | 河北中天邦正生物科技股份公司 | 一种农药组合物及其应用 |
| US11958903B2 (en) | 2018-03-30 | 2024-04-16 | Nanjing Legend Biotech Co., Ltd. | Single-domain antibodies against LAG-3 and uses thereof |
| US12084489B2 (en) | 2018-05-02 | 2024-09-10 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Antibodies and methods for the diagnosis, prevention, and treatment of Epstein Barr virus infection |
| JP7382970B2 (ja) | 2018-06-08 | 2023-11-17 | アレクトル エルエルシー | 抗Ｓｉｇｌｅｃ－７抗体及びその使用方法 |
| SG11202012342WA (en) | 2018-06-18 | 2021-01-28 | Eureka Therapeutics Inc | Constructs targeting prostate-specific membrane antigen (psma) and uses thereof |
| KR20210031898A (ko) | 2018-07-13 | 2021-03-23 | 난징 레전드 바이오테크 씨오., 엘티디. | 전염병을 치료하기 위한 공동수용체 시스템 |
| PE20210186A1 (es) | 2018-07-13 | 2021-02-02 | Alector Llc | Anticuerpos anti-sortilina y metodos para su uso |
| EA202190183A1 (ru) | 2018-07-27 | 2021-05-18 | Алектор Ллс | Антитела к siglec-5 и способы их применения |
| AU2019331018A1 (en) | 2018-08-31 | 2021-03-11 | Alector Llc | Anti-cd33 antibodies and methods of use thereof |
| US20220105176A1 (en) | 2018-09-12 | 2022-04-07 | Acm Biolabs Pte Ltd | Polymersomes comprising a covalently bound antigen as well as methods of making and uses thereof |
| CA3112486A1 (en) | 2018-09-14 | 2020-03-19 | The Rockefeller University | Anti-hiv antibody 10-1074 variants |
| US12129305B2 (en) | 2018-10-25 | 2024-10-29 | The Medical College Of Wisconsin, Inc. | Targeting CLPTM1L for treatment and prevention of cancer |
| RU2724469C2 (ru) | 2018-10-31 | 2020-06-23 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело, которое специфически связывается с cd20 |
| EP4640698A2 (en) | 2018-11-16 | 2025-10-29 | Memorial Sloan Kettering Cancer Center | Antibodies to mucin-16 and methods of use thereof |
| CA3120729A1 (en) | 2018-11-27 | 2020-06-04 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing granulocyte-macrophage colony stimulating factor receptor alpha and uses thereof |
| RU2734432C1 (ru) | 2019-04-23 | 2020-10-16 | Закрытое Акционерное Общество "Биокад" | Моноклональное антитело, которое специфически связывается с GITR |
| WO2020222573A1 (ko) | 2019-05-02 | 2020-11-05 | 주식회사 레고켐 바이오사이언스 | 트리스 구조를 가지는 링커를 포함하는 리간드-약물 접합체 |
| JP2022538293A (ja) | 2019-06-28 | 2022-09-01 | ジェネンテック， インコーポレイテッド | 液体タンパク質製剤を安定化するための組成物及び方法 |
| CN110178842A (zh) * | 2019-07-05 | 2019-08-30 | 南京农业大学 | 一种丙草胺与双唑草腈治理抗性稗组合物及其应用 |
| AU2020311511B2 (en) | 2019-07-09 | 2024-08-29 | Beijing Solobio Genetechnology Co., Ltd. | Antibodies specifically recognizing Pseudomonas PcrV and uses thereof |
| JP2022540806A (ja) | 2019-07-19 | 2022-09-20 | オンコレスポンス，インク． | 免疫調節抗体およびその使用方法 |
| CN112300279A (zh) | 2019-07-26 | 2021-02-02 | 上海复宏汉霖生物技术股份有限公司 | 针对抗cd73抗体和变体的方法和组合物 |
| WO2021238886A1 (en) | 2020-05-27 | 2021-12-02 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing nerve growth factor and uses thereof |
| BR112023014418A2 (pt) | 2021-01-20 | 2023-10-31 | Oncoresponse Inc | Anticorpos imunomoduladores e usos dos mesmos |
| JP2024518710A (ja) | 2021-04-12 | 2024-05-02 | エイシーエム バイオラブズ プライベート リミテッド | 可溶性封入ポリヌクレオチドとイオン化可能脂質とを含むポリマーソームならびにその作製および使用方法 |
| US20250011448A1 (en) | 2021-07-08 | 2025-01-09 | Staidson Biopharma Inc. | Antibodies specifically recognizing tnfr2 and uses thereof |
| JP2024525769A (ja) | 2021-07-14 | 2024-07-12 | 舒泰神（北京）生物製薬股フン有限公司 | Ｃｄ４０を特異的に認識する抗体およびその使用 |
| EP4445911A4 (en) | 2021-12-06 | 2025-10-22 | Beijing Solobio Genetechnology Co Ltd | BISPECIFIC ANTIBODY THAT BINDS SPECIFICALLY TO KLEBSIELLA PNEUMONIAE O1 AND O2 ANTIGENS AND COMPOSITION |
| WO2023217068A1 (zh) | 2022-05-09 | 2023-11-16 | 舒泰神（北京）生物制药股份有限公司 | 特异性识别gdf15的抗体及其应用 |
| TW202417503A (zh) | 2022-07-19 | 2024-05-01 | 美商舒泰神（加州）生物科技有限公司 | 特異性識別ｂ和ｔ淋巴細胞衰減器（ｂｔｌａ）的抗體及其應用 |
| CN119998321A (zh) | 2022-09-27 | 2025-05-13 | 舒泰神（北京）生物制药股份有限公司 | 特异性识别light的抗体及其应用 |
| JP2025535386A (ja) | 2022-10-20 | 2025-10-24 | 北京三▲諾▼佳邑生物技▲術▼有限▲責▼任公司 | ＴＲＡＩＬまたはＦａｓＬに特異的に結合する抗体の組み合わせおよび二重特異性抗体 |
| WO2025224166A1 (en) | 2024-04-23 | 2025-10-30 | F. Hoffmann-La Roche Ag | Anti-drug antibody assays |
| WO2025233867A1 (en) | 2024-05-10 | 2025-11-13 | Adaptam Therapeutics, S.L. | Anti-siglec-9 antibodies and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY136106A (en) * | 1990-09-06 | 2008-08-29 | Novartis Ag | Synergistic composition comprising a sulfonylurea anda thiadiazolo (3,4-a)pyridazine and method of selective weed control. |
| IL116507A (en) * | 1991-11-13 | 1997-08-14 | Schering Ag | Pyrazole derivatives |
| HU219150B (hu) * | 1992-10-12 | 2001-02-28 | Schering Ag. | Új szubsztituált pirazolszármazékok, eljárás azok előállítására, valamint herbicidként történő alkalmazásuk |
-
1995
- 1995-11-15 DE DE19544393A patent/DE19544393A1/de not_active Withdrawn
-
1996
- 1996-11-12 ES ES96938177T patent/ES2178720T3/es not_active Expired - Lifetime
- 1996-11-12 JP JP51856597A patent/JP3920341B2/ja not_active Expired - Lifetime
- 1996-11-12 US US09/068,137 patent/US6013605A/en not_active Expired - Lifetime
- 1996-11-12 CA CA002236592A patent/CA2236592C/en not_active Expired - Lifetime
- 1996-11-12 EP EP96938177A patent/EP0863705B1/de not_active Expired - Lifetime
- 1996-11-12 BR BR9611478A patent/BR9611478A/pt not_active IP Right Cessation
- 1996-11-12 RU RU98111619/04A patent/RU2170017C2/ru not_active IP Right Cessation
- 1996-11-12 WO PCT/EP1996/004935 patent/WO1997017852A1/de not_active Ceased
- 1996-11-12 DE DE59609348T patent/DE59609348D1/de not_active Expired - Fee Related
- 1996-11-12 KR KR10-1998-0703305A patent/KR100427960B1/ko not_active Expired - Lifetime
- 1996-11-12 TR TR1998/00794T patent/TR199800794T2/xx unknown
- 1996-11-12 CN CN96198102A patent/CN1084148C/zh not_active Expired - Lifetime
- 1996-11-12 AU AU75696/96A patent/AU711841B2/en not_active Expired
- 1996-11-13 TW TW085113810A patent/TW355125B/zh not_active IP Right Cessation
- 1996-11-13 MY MYPI96004700A patent/MY114731A/en unknown
- 1996-11-14 ZA ZA969564A patent/ZA969564B/xx unknown
- 1996-12-11 UA UA98063093A patent/UA48203C2/uk unknown
-
1998
- 1998-05-14 MX MX9803824A patent/MX9803824A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0863705B1 (de) | 2002-06-12 |
| DE19544393A1 (de) | 1997-05-22 |
| AU7569696A (en) | 1997-06-05 |
| MX9803824A (es) | 1998-09-30 |
| CA2236592A1 (en) | 1997-05-22 |
| CN1201370A (zh) | 1998-12-09 |
| WO1997017852A1 (de) | 1997-05-22 |
| RU2170017C2 (ru) | 2001-07-10 |
| CN1084148C (zh) | 2002-05-08 |
| TR199800794T2 (xx) | 1998-08-21 |
| AU711841B2 (en) | 1999-10-21 |
| EP0863705A1 (de) | 1998-09-16 |
| JP2000500445A (ja) | 2000-01-18 |
| KR19990067314A (ko) | 1999-08-16 |
| ES2178720T3 (es) | 2003-01-01 |
| CA2236592C (en) | 2005-01-04 |
| MY114731A (en) | 2002-12-31 |
| JP3920341B2 (ja) | 2007-05-30 |
| TW355125B (en) | 1999-04-01 |
| BR9611478A (pt) | 1999-07-13 |
| UA48203C2 (uk) | 2002-08-15 |
| ZA969564B (en) | 1997-05-15 |
| US6013605A (en) | 2000-01-11 |
| DE59609348D1 (de) | 2002-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100427960B1 (ko) | 상승 작용성 제초제 혼합물 | |
| DK2170052T3 (en) | Synergistic CULTURE PLANT SETTLEMENT RIGHT COMBINATION CONTAINING HERBICIDES FROM THE GROUP OF benzoyl cyclohexanediones FOR USE IN RISKULTURER | |
| US9999221B2 (en) | Herbicide combination containing pelargonic acid and defined ALS inhibitors | |
| CA3078669C (en) | HERBICIDAL COMPOSITION WITH SYNERGISTIC EFFICACY COMPRISING PELARGONIC ACID AND FLAZASULFURON | |
| PL211233B1 (pl) | Środek chwastobójczy, sposób zwalczania szkodliwych roślin, zastosowanie środka chwastobójczego i sposób wytwarzania środka chwastobójczego | |
| CZ20024139A3 (cs) | Herbicidní prostředek a způsob hubení škodlivých rostlin | |
| ZA200403326B (en) | Synergistic herbicidal compositions comprising herbicides from the group of the benzoylpyrazoles | |
| AU2006228738B2 (en) | Synergistic herbicidal agents that are compatible with cultivated plants, said agents containing herbicides from the group comprising benzoyl pyrazoles | |
| US6239070B1 (en) | Herbicidal mixtures | |
| KR100479612B1 (ko) | 1-(2-클로로-페닐)-4-(n-사이클로헥실-n-에틸-아미노카보닐)-1,4-디하이드로-5h-테트라졸-5-온및프로파닐을기본으로한선택적제초제 | |
| KR0171909B1 (ko) | 상승작용을 갖는 벤푸레세이트 혼합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 19980504 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20011109 Comment text: Request for Examination of Application |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20040226 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20040408 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20040409 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20070402 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20080319 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20090406 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20100318 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20110310 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 20120319 Start annual number: 9 End annual number: 9 |
|
| FPAY | Annual fee payment |
Payment date: 20130311 Year of fee payment: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20130311 Start annual number: 10 End annual number: 10 |
|
| FPAY | Annual fee payment |
Payment date: 20140305 Year of fee payment: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20140305 Start annual number: 11 End annual number: 11 |
|
| FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20150306 Start annual number: 12 End annual number: 12 |
|
| FPAY | Annual fee payment |
Payment date: 20160304 Year of fee payment: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20160304 Start annual number: 13 End annual number: 13 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |
Termination date: 20170512 Termination category: Expiration of duration |